Comprehensive retinal vascular measurements: time in range is associated with peripheral retinal venular calibers in type 2 diabetes in China.

Diabetic microangiopathy Peripheral venular caliber Retinal vasculature Time in range Type 2 diabetes

Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 20 03 2023
accepted: 14 05 2023
medline: 24 7 2023
pubmed: 6 6 2023
entrez: 5 6 2023
Statut: ppublish

Résumé

Retinal vascular parameters are biomarkers of diabetic microangiopathy. We aimed to investigate the relationship between time in range (TIR) assessed by continuous glucose monitoring (CGM) and retinal vascular parameters in patients with type 2 diabetes in China. The TIR assessed by CGM and retinal photographs were obtained at the same time from adults with type 2 diabetes who were recruited. Retinal vascular parameters were extracted from retinal photographs by a validated fully automated computer program, and TIR was defined as between 3.9-7.8 mmol/L over a 24-h period. The association between TIR and caliber of retinal vessels distributed in different zones were analyzed using multivariable linear regression analyses. For retinal vascular parameters measurements, the peripheral arteriovenous and middle venular calibers widen with decreasing TIR quartiles (P < 0.05). Lower TIR was associated with wider peripheral venule after adjusting for potential confounders. Even after further correction for GV, there was still a significant correlation between TIR and peripheral vascular calibers (CV: β = - 0.015 [- 0.027, - 0.003], P = 0.013; MAGE: β = - 0.013 [- 0.025, - 0.001], P = 0.038) and SD: β = - 0.013 [- 0.026, - 0.001], P = 0.004). Similar findings were not found for the middle and central venular calibers or arterial calibers located in different zones. The TIR was associated with adverse changes to peripheral retinal venules but not central and middle vessels in patients with type 2 diabetes, suggesting that peripheral retinal vascular calibers may be affected by glycemic fluctuations earlier.

Identifiants

pubmed: 37277658
doi: 10.1007/s00592-023-02120-0
pii: 10.1007/s00592-023-02120-0
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1267-1277

Subventions

Organisme : Natural Science Foundation of Shaanxi Province
ID : 2022JM-438
Organisme : Natural Science Foundation of Shaanxi Province
ID : 2023-JC-YB-742
Organisme : Key Research and Development Projects of Shaanxi Province
ID : 2023-ZDLSF-40

Informations de copyright

© 2023. Springer-Verlag Italia S.r.l., part of Springer Nature.

Références

Madonna R, Balistreri CR, Geng YJ, De Caterina R (2017) Diabetic microangiopathy: pathogenetic insights and novel therapeutic approaches. Vascul Pharmacol 90:1–7. https://doi.org/10.1016/j.vph.2017.01.004
doi: 10.1016/j.vph.2017.01.004 pubmed: 28137665
Grauslund J (2022) Diabetic retinopathy screening in the emerging era of artificial intelligence. Diabetologia 65(9):1415–1423. https://doi.org/10.1007/s00125-022-05727-0
doi: 10.1007/s00125-022-05727-0 pubmed: 35639120
Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42(8):1593–1603. https://doi.org/10.2337/dci19-0028
doi: 10.2337/dci19-0028 pubmed: 31177185 pmcid: 6973648
Lu J, Ma X, Zhou J et al (2018) Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care 41(11):2370–2376. https://doi.org/10.2337/dc18-1131
doi: 10.2337/dc18-1131 pubmed: 30201847
Mayeda L, Katz R, Ahmad I et al (2020) Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease. BMJ Open Diabetes Res Care. https://doi.org/10.1136/bmjdrc-2019-000991
doi: 10.1136/bmjdrc-2019-000991 pubmed: 31958307 pmcid: 7039577
Foreman YD, van Doorn W, Schaper NC et al (2021) Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: the maastricht study. Diabetologia 64(8):1880–1892. https://doi.org/10.1007/s00125-021-05474-8
doi: 10.1007/s00125-021-05474-8 pubmed: 33991193 pmcid: 8245390
Beck RW, Bergenstal RM, Riddlesworth TD et al (2019) Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care 42(3):400–405. https://doi.org/10.2337/dc18-1444
doi: 10.2337/dc18-1444 pubmed: 30352896
Nguyen TT, Wang JJ, Sharrett AR et al (2008) Relationship of retinal vascular caliber with diabetes and retinopathy: the multi-ethnic study of atherosclerosis (MESA). Diabetes Care 31(3):544–549. https://doi.org/10.2337/dc07-1528
doi: 10.2337/dc07-1528 pubmed: 18070990
Yang X, Deng Y, Gu H et al (2016) Relationship of retinal vascular calibre and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus: the Desheng Diabetic Eye Study. Br J Ophthalmol 100(10):1359–1365. https://doi.org/10.1136/bjophthalmol-2014-306078
doi: 10.1136/bjophthalmol-2014-306078 pubmed: 26823397
Xu X, Gao B, Ding W et al (2021) Retinal image measurements and their association with chronic kidney disease in Chinese patients with type 2 diabetes: the NCD study. Acta Diabetol 58(3):363–370. https://doi.org/10.1007/s00592-020-01621-6
doi: 10.1007/s00592-020-01621-6 pubmed: 33098472
Li W, Schram MT, Berendschot T et al (2020) Type 2 diabetes and HbA1c are independently associated with wider retinal arterioles: the maastricht study. Diabetologia 63(7):1408–1417. https://doi.org/10.1007/s00125-020-05146-z
doi: 10.1007/s00125-020-05146-z pubmed: 32385602 pmcid: 7286946
Chua J, Chia AR, Chee ML et al (2018) The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes. Sci Rep 8(1):730. https://doi.org/10.1038/s41598-017-18930-6
doi: 10.1038/s41598-017-18930-6 pubmed: 29335432 pmcid: 5768794
Meyer ML, Klein BE, Klein R et al (2020) Central arterial stiffness and retinal vessel calibers: the atherosclerosis risk in communities study-neurocognitive study. J Hypertens 38(2):266–273. https://doi.org/10.1097/HJH.0000000000002252
doi: 10.1097/HJH.0000000000002252 pubmed: 31584520 pmcid: 6949400
Cheung CY, Xu D, Cheng CY et al (2021) A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre. Nat Biomed Eng 5(6):498–508. https://doi.org/10.1038/s41551-020-00626-4
doi: 10.1038/s41551-020-00626-4 pubmed: 33046867
Hu Y, Niu Y, Wang D, Wang Y, Holden BA, He M (2015) The association of longitudinal trend of fasting plasma glucose with retinal microvasculature in people without established diabetes. Invest Ophthalmol Vis Sci 56(2):842–848. https://doi.org/10.1167/iovs.14-15943
doi: 10.1167/iovs.14-15943 pubmed: 25613941
Bek T (2017) Diameter changes of retinal vessels in diabetic retinopathy. Curr Diab Rep 17(10):82. https://doi.org/10.1007/s11892-017-0909-9
doi: 10.1007/s11892-017-0909-9 pubmed: 28791532
Tsai AS, Wong TY, Lavanya R et al (2011) Differential association of retinal arteriolar and venular caliber with diabetes and retinopathy. Diabetes Res Clin Pract 94(2):291–298. https://doi.org/10.1016/j.diabres.2011.07.032
doi: 10.1016/j.diabres.2011.07.032 pubmed: 21864932
Safi H, Safi S, Hafezi-Moghadam A, Ahmadieh H (2018) Early detection of diabetic retinopathy. Surv Ophthalmol 63(5):601–608. https://doi.org/10.1016/j.survophthal.2018.04.003
doi: 10.1016/j.survophthal.2018.04.003 pubmed: 29679616
Wurm M, Kuhnemund L, Maier L et al (2019) Hemoglobin A1c and retinal arteriolar narrowing in children with type 1 diabetes: the diagnostics of early atherosclerosis risk in kids study. Pediatr Diabetes 20(5):622–628. https://doi.org/10.1111/pedi.12858
doi: 10.1111/pedi.12858 pubmed: 30993848
Velayutham V, Benitez-Aguirre PZ, Craig ME et al (2017) Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes. Diabetologia 60(10):2103–2110. https://doi.org/10.1007/s00125-017-4375-3
doi: 10.1007/s00125-017-4375-3 pubmed: 28711971
Xu X, Sun F, Wang Q et al (2020) Comprehensive retinal vascular measurements: a novel association with renal function in type 2 diabetic patients in China. Sci Rep 10(1):13737. https://doi.org/10.1038/s41598-020-70408-0
doi: 10.1038/s41598-020-70408-0 pubmed: 32792602 pmcid: 7426409
Bucca BC, Maahs DM, Snell-Bergeon JK et al (2018) Dynamic changes in retinal vessel diameter during acute hyperglycemia in type 1 diabetes. J Diabetes Complicat 32(2):234–239. https://doi.org/10.1016/j.jdiacomp.2017.10.001
doi: 10.1016/j.jdiacomp.2017.10.001
Hafner J, Ginner L, Karst S et al (2017) Regional patterns of retinal oxygen saturation and microvascular hemodynamic parameters preceding retinopathy in patients with type 2 diabetes. Invest Ophthalmol Vis Sci 58(12):5541–5547. https://doi.org/10.1167/iovs.17-22523
doi: 10.1167/iovs.17-22523 pubmed: 29075765
Rasmussen ML, Broe R, Frydkjaer-Olsen U et al (2017) Retinal vascular geometry and its association to microvascular complications in patients with type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987). Graefes Arch Clin Exp Ophthalmol 255(2):293–299. https://doi.org/10.1007/s00417-016-3454-3
doi: 10.1007/s00417-016-3454-3 pubmed: 27520462
Liu L, Ke W, Xu L et al (2023) Evaluating the role of time in range as a glycemic target during short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. J Diabetes 15(2):133–144. https://doi.org/10.1111/1753-0407.13355
doi: 10.1111/1753-0407.13355 pubmed: 36650669 pmcid: 9934958
Goldenberg RM, Aroda VR, Billings LK et al (2021) Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia. Diabetes Obes Metab 23(11):2572–2581. https://doi.org/10.1111/dom.14504
doi: 10.1111/dom.14504 pubmed: 34322967 pmcid: 9290717
Wang Q, Yang A, Sun F, Zhang M, Xu X, Gao B (2021) Correlation between retinal vascular parameters and cystatin C in patients with type 2 diabetes. Acta Diabetol 58(10):1395–1401. https://doi.org/10.1007/s00592-021-01741-7
doi: 10.1007/s00592-021-01741-7 pubmed: 34019155
Hu G, Wu H, Kuang L et al (2021) Clinical study of diabetic peripheral neuropathy screening by retinal vascular geometric parameters. Sci Rep 11(1):6784. https://doi.org/10.1038/s41598-021-85831-0
doi: 10.1038/s41598-021-85831-0 pubmed: 33762602 pmcid: 7990935
Pemp B, Schmetterer L (2008) Ocular blood flow in diabetes and age-related macular degeneration. Can J Ophthalmol 43(3):295–301. https://doi.org/10.3129/i08-049
doi: 10.3129/i08-049 pubmed: 18443612
Bek T (2013) Regional morphology and pathophysiology of retinal vascular disease. Prog Retin Eye Res 36:247–259. https://doi.org/10.1016/j.preteyeres.2013.07.002
doi: 10.1016/j.preteyeres.2013.07.002 pubmed: 23892140
Nguyen TT, Wang JJ, Wong TY (2007) Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care 30(10):2708–2715. https://doi.org/10.2337/dc07-0732
doi: 10.2337/dc07-0732 pubmed: 17595350
Owen CG, Rudnicka AR, Welikala RA et al (2019) retinal vasculometry associations with cardiometabolic risk factors in the European prospective investigation of cancer-norfolk study. Ophthalmology 126(1):96–106. https://doi.org/10.1016/j.ophtha.2018.07.022
doi: 10.1016/j.ophtha.2018.07.022 pubmed: 30075201
Jorgensen CM, Bek T (2017) Lack of differences in the regional variation of oxygen saturation in larger retinal vessels in diabetic maculopathy and proliferative diabetic retinopathy. Br J Ophthalmol 101(6):752–757. https://doi.org/10.1136/bjophthalmol-2016-308894
doi: 10.1136/bjophthalmol-2016-308894 pubmed: 27553678
Silva PS, Cavallerano JD, Sun JK, Soliman AZ, Aiello LM, Aiello LP (2013) Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity. Ophthalmology 120(12):2587–2595. https://doi.org/10.1016/j.ophtha.2013.05.004
doi: 10.1016/j.ophtha.2013.05.004 pubmed: 23778092
Broe R, Rasmussen ML, Frydkjaer-Olsen U et al (2014) Retinal vascular fractals predict long-term microvascular complications in type 1 diabetes mellitus: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987). Diabetologia 57(10):2215–2221. https://doi.org/10.1007/s00125-014-3317-6
doi: 10.1007/s00125-014-3317-6 pubmed: 24981770
Benitez-Aguirre P, Craig ME, Sasongko MB et al (2011) Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence. Diabetes Care 34(7):1622–1627. https://doi.org/10.2337/dc10-2419
doi: 10.2337/dc10-2419 pubmed: 21593293 pmcid: 3120178
Heinemann L, Freckmann G, Muller-Wieland D, Kellerer M (2020) Critical reappraisal of the time-in-range: alternative or useful addition to glycated hemoglobin? J Diabetes Sci Technol 14(5):922–927. https://doi.org/10.1177/1932296819883885
doi: 10.1177/1932296819883885 pubmed: 31675907
Lu J, Wang C, Shen Y et al (2021) Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study. Diabetes Care 44(2):549–555. https://doi.org/10.2337/dc20-1862
doi: 10.2337/dc20-1862 pubmed: 33097560
Zhou Z, Sun B, Huang S, Zhu C, Bian M (2020) Glycemic variability: adverse clinical outcomes and how to improve it? Cardiovasc Diabetol 19(1):102. https://doi.org/10.1186/s12933-020-01085-6
doi: 10.1186/s12933-020-01085-6 pubmed: 32622354 pmcid: 7335439
Stem MS, Dunbar GE, Jackson GR, Farsiu S, Pop-Busui R, Gardner TW (2016) Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus. Eye (Lond) 30(6):825–832. https://doi.org/10.1038/eye.2016.48
doi: 10.1038/eye.2016.48 pubmed: 27034201
Picconi F, Parravano M, Ylli D et al (2017) Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability. Acta Diabetol 54(5):489–497. https://doi.org/10.1007/s00592-017-0971-4
doi: 10.1007/s00592-017-0971-4 pubmed: 28238189 pmcid: 5385321

Auteurs

Guohong Zhao (G)

Department of Endocrinology, Shaanxi Province, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, People's Republic of China.

Xiayu Xu (X)

The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China.
Bioinspired Engineering and Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China.

Xinwen Yu (X)

Department of Endocrinology, Shaanxi Province, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, People's Republic of China.

Fei Sun (F)

Department of Endocrinology, Shaanxi Province, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, People's Republic of China.

Aili Yang (A)

Department of Endocrinology, Shaanxi Province, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, People's Republic of China.

Yuxin Jin (Y)

Department of Endocrinology, Shaanxi Province, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, People's Republic of China.

Jing Huang (J)

Department of Health Management, Shaanxi Province, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, People's Republic of China.

Jing Wei (J)

Department of Endocrinology, Shaanxi Province, Xi'an Gaoxin Hospital, Xi'an, 710100, People's Republic of China. xi_anwj@126.com.

Bin Gao (B)

Department of Endocrinology, Shaanxi Province, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, People's Republic of China. bingao0726@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH